Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.
about
Case-control cohort study of patients' perceptions of disability in mastocytosisThe alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosisThe B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pHManagement and Prevention of AnaphylaxisMast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research ProgramGeneration of anaphylatoxins by human beta-tryptase from C3, C4, and C5Navigating the updated anaphylaxis parameters.Genetic deficiency of human mast cell alpha-tryptase.Emergency medical treatment of anaphylactic reactions. Project Team of the Resuscitation Council (UK)Desensitization protocols for vancomycin hypersensitivity.Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcomeAnti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalIncreased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosisSerum tryptase levels in atopic and nonatopic children.The serum tryptase test: an emerging robust biomarker in clinical hematology.Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivoInterleukin-3 does not affect the differentiation of mast cells derived from human bone marrow progenitorsNon-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis.How to interpret mast cell tests.Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.Anaphylaxis with midazolam - Our experience.Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line.A novel combination of an IgE mediated adult onset food allergy and a suspected mast cell activation syndrome presenting as anaphylaxis.Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report.Mast cell number, phenotype, and function in human pulmonary arterial hypertension.Anaphylaxis to vecuronium: A rare event.Assessing anaphylactic risk? Consider mast cell clonality.Factors influencing serum total tryptase concentrations in a general adult population.In Vitro Research Tools in the Field of Human Immediate Drug Hypersensitivity and Their Present Use in Small Animal Veterinary Medicine.Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis?Importance of serum basal tryptase levels in children with insect venom allergy.Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms.Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymaSerum B12 tryptase level as a marker of allergic airway inflammation in asthma.Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.Life-threatening pulmonary hypertension and right ventricular failure complicating calcium and phosphate replacement in the intensive care unit.
P2860
Q21092209-ABE7FAC0-1745-4005-9E35-E7EC1FA20C35Q24676988-79E835AC-0099-444C-BC13-A5DB18772B07Q24683592-8BD79D13-3DE9-4054-8152-B9E8CB3A3BADQ26766190-60F1A21E-0E8D-4A16-A369-F8C86CFC0759Q30428466-51530A3D-0AF3-4F84-B7E3-1645631F2CE2Q30439751-F16A5FA9-7C91-46AF-B350-10EF18297748Q33864947-7A0FF454-CFFC-4592-865A-5E8519089C15Q34137182-40F368FC-E59E-4C1E-AEBF-DE1130192609Q34293313-09B2886B-62D4-4290-8376-DE6A199DA07BQ34449467-05C68116-C7F2-44F4-AE3D-E380C102B588Q35025246-D8B04D88-A624-4E3F-AE7E-0F65472F7044Q35556806-6193CD4C-F74F-4108-8806-B8EDFB4C9C5BQ35574171-92C0154C-9CD0-4308-B3AB-F2C4C3AFEED2Q35951578-BDE225AD-5DCF-4859-A640-10B921EEE62AQ36108210-26EC0D23-F8FD-438D-967E-986A76A1D37CQ36154674-8F92CDD5-42AA-4A14-BD4F-10B146CDCE81Q36330511-B1F8EA4B-A346-4C78-A302-DF1F4D54CB6CQ36366794-D77076DB-F69A-4B1E-9B68-7137302465B8Q36725227-A4656CE8-C740-4599-AEA8-0A4B300A557AQ37729070-A9ACB9B2-698B-4024-86C2-F3AE96251348Q38736625-7417C7ED-9564-40F4-B5A8-400964A64F34Q38764567-D3CEFAF6-4B1A-46A2-805A-E2380C07D1ABQ38850401-40907754-8650-470C-A441-01A12CD59F83Q38968266-A4D71D2E-1EF8-4BC9-AF1A-2166F09A06BBQ40110521-5907E9BA-8F3E-47E1-90D2-EF1CFCEB4A72Q40190058-22652013-719C-425C-B4A7-00C83193AC50Q41114990-AE54EDF0-2255-4176-8291-1AF60D43EFECQ42093252-72E9ADC4-AAFF-4C60-8B90-E1AB1B38D593Q42244910-29413F16-60FD-4420-A1FF-497AFB26ACFEQ42252551-57EF934E-7DBE-417E-841F-32AB0A11B095Q42665868-2DF0A347-BCEA-4F1A-8DF3-C043F9BF99A0Q43152972-A571DEDF-C4B0-4AB0-BC89-9B615A536F51Q43378563-2DD313F0-08E9-46C7-A931-B9B110A31147Q43696284-0D90A468-273E-4D32-91F9-F62E2CD4B358Q43752714-C1A9B1FF-C054-45D2-9957-474DB138C1DCQ43771586-2B78090C-335C-4126-9671-58C8FFC38FC5Q44016393-064322AC-BCF2-496F-99AE-95251511BA9CQ44048596-63417B0B-42DD-4F74-BDB0-215F2E5F64A1Q44863693-0DF1D5C5-D151-4334-A61C-279C36F75158Q46892181-F6F81802-D10E-4561-AB0D-BC7F69AF71F3
P2860
Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Development of a new, more sen ...... : use in systemic anaphylaxis.
@en
Development of a new, more sen ...... : use in systemic anaphylaxis.
@nl
type
label
Development of a new, more sen ...... : use in systemic anaphylaxis.
@en
Development of a new, more sen ...... : use in systemic anaphylaxis.
@nl
prefLabel
Development of a new, more sen ...... : use in systemic anaphylaxis.
@en
Development of a new, more sen ...... : use in systemic anaphylaxis.
@nl
P2093
P356
P1476
Development of a new, more sen ...... e: use in systemic anaphylaxis
@en
P2093
J K Van der Zwan
L B Schwartz
P W Van der Linden
T R Bradford
P2888
P304
P356
10.1007/BF01533368
P50
P577
1994-05-01T00:00:00Z
P6179
1033178861